Digital Therapeutics: Catalyzing Personalized Medicine and the Pursuit of Equitable Healthcare

The evolution of digital therapeutics reflects a transformative shift in personalized healthcare, propelled by software-driven interventions aimed at preventing, managing, and treating a plethora of medical conditions with evidence-based approaches. This editorial articulates the burgeoning role of...

Full description

Saved in:
Bibliographic Details
Main Author: Chetan Choudhary (Author)
Format: Book
Published: Research Center for Rational Use of Drugs (RCRUD), 2024-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e5f5cb8d23d245dea77d3e48068c2039
042 |a dc 
100 1 0 |a Chetan Choudhary  |e author 
245 0 0 |a Digital Therapeutics: Catalyzing Personalized Medicine and the Pursuit of Equitable Healthcare 
260 |b Research Center for Rational Use of Drugs (RCRUD),   |c 2024-06-01T00:00:00Z. 
500 |a 2322-4630 
500 |a 2322-4509 
520 |a The evolution of digital therapeutics reflects a transformative shift in personalized healthcare, propelled by software-driven interventions aimed at preventing, managing, and treating a plethora of medical conditions with evidence-based approaches. This editorial articulates the burgeoning role of DTx as an integral component of modern healthcare, distinct from traditional therapy methods through its direct delivery of therapeutic measures via software. The importance of a digital therapeutic alliance is emphasized for enhancing patient engagement and adherence, with a nod to the literature suggesting promising outcomes in various domains including neurology, psychiatry, and general medicine. The paper reviews the promising applications of DTx, such as game-based interventions for younger patients and strategies targeting chronic conditions like Parkinson's disease, which have seen a surge in relevance amidst the pandemic stressors. It also highlights the response from regulatory bodies, particularly the FDA, in recognizing and promoting the safe integration of DTx into clinical practice. The editorial further discusses the pivotal challenges and opportunities ahead, emphasizing the need for continued innovation, regulation, and collaboration between stakeholders to ensure not only the expansion but also the efficacy and safety of DTx. As the medical community seeks to harness these advancements, this editorial underscores the transformative potential of DTx to democratize and enhance health outcomes, setting the stage for a new era in medicine.   
546 |a EN 
690 |a digital therapeutics 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmaceutical Care, Vol 12, Iss 2 (2024) 
787 0 |n https://jpc.tums.ac.ir/index.php/jpc/article/view/690 
787 0 |n https://doaj.org/toc/2322-4630 
787 0 |n https://doaj.org/toc/2322-4509 
856 4 1 |u https://doaj.org/article/e5f5cb8d23d245dea77d3e48068c2039  |z Connect to this object online.